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During 2006–2015, we analyzed 70 dengue virus (DENV) 
strains isolated from febrile travelers returning to Germa-
ny. High genetic diversity, including multiple co-circulating 
DENV lineages and emerging new lineages of DENV-3 and 
DENV-4, was demonstrated. Our passive surveillance sys-
tem based on returning travelers yielded substantial infor-
mation on DENV diversity.
Although dengue virus (DENV) infects ≈390 million persons  annually and one third of the world’s popu-
lation is at risk for infection, there is no effective vaccine 
or specific antiviral therapy for infection with DENV  (1). 
Dengue is a rapidly spreading mosquito-borne viral disease 
and the most frequent cause of febrile illness among inter-
national travelers returning from DENV-endemic tropical 
areas, such as Southeast Asia, the western Pacific region, 
and the Americas (2,3). Viremic travelers have the potential 
to introduce DENV into DENV-free or nonendemic areas 
where competent mosquito vectors are present (4). Reintro-
duction of DENV in regions that had been considered free 
of the disease for many years has also been observed (5–7).
Phylogenetic analysis has elucidated the origins, epide-
miology, and forces that shape DENV molecular evolution 
in nature (8). For example, according to official German air 
travel statistics reports, 4,855,763 air trips were taken in 
2011 from Germany to countries listed as DENV-endemic 
areas by the World Health Organization; 10%–20% each 
of these trips were made to India, Thailand, and Brazil; and 
5%–10% each flew to Singapore, Mexico, and the Domini-
can Republic (9). We determined the genetic relatedness 
and molecular epidemiology of DENV isolates from travel-
ers returning to Germany during 2006–2015.
The Study
During 2006–2015, we analyzed 15,876 acute-phase serum 
samples from patients with suspected DENV infection; the 
samples had been submitted to the World Health Organiza-
tion Collaborating Centre for Arbovirus and Hemorrhagic 
Fever Reference and Research for diagnostic testing. We 
tested all samples by using DENV type-specific real-time 
reverse transcription PCR (rRT-PCR) (10) or an antigen-
capture ELISA (Platelia Dengue NS1 Ag; Bio-Rad, Hercu-
les, CA, USA) and in-house DENV IgG and IgM indirect 
immunofluorescence assays. rRT-PCR– and nonstructural 
protein 1–positive serum samples that tested negative for 
DENV IgG and IgM were spread onto Vero E6 cells and 
incubated for 7 days at 37°C; successful DENV isolation 
was identified by rRT-PCR. We extracted viral RNA from 
cell culture supernatants by using the QIAamp Viral RNA 
Mini Kit (QIAGEN, Hilden, Germany). 
We successfully isolated 70 DENV strains originating 
from 20 countries (online Technical Appendix, http://ww-
wnc.cdc.gov/EID/article/23/2/16-0751-Techapp1.pdf). We 
amplified the complete envelope glycoprotein (E) gene us-
ing DENV type–specific degenerate primers (online Tech-
nical Appendix). Sequence assembly, analysis, and mul-
tiple alignments were performed with Geneious version 
7.1.8 (Biomatters, Auckland, New Zealand). All available 
complete envelope gene sequences of DENV serotypes 
1–4 (DENV-1–4), except laboratory strains and potential 
recombinants, were retrieved from GenBank and compared 
with those sequenced in this study. The phylogenetic rela-
tionships and origin of the imported DENV isolates were 
analyzed by the maximum likelihood method in the RAx-
ML program (11) with general time-reversible plus gamma 
distribution  substitution model and a rapid bootstrap (100 
replicates) procedure, and visualized in FigTree version 
1.4.3 (http://tree.bio.ed.ac.uk/software/figtree/). 
Most DENV infections were acquired in Thailand 
(35.7%), followed by Indonesia (12.8%), the Philippines 
(10%), and India (7.1%). The proportion of cases imported 
from other  countries in Asia, Africa, and the Americas 
ranged between 1.4% and 4.3% (Figures 1, 2). Phyloge-
netic analysis revealed a high genetic diversity of DENV-
1–4 in travelers from Germany, including co-circulation 
of multiple genetically diverse viral lineages that were 
closely related to those previously circulating in the Amer-
icas and Southeast Asia (mostly Thailand, Indonesia, and 
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the Philippines) (online Technical Appendix). DENV-1 
was the predominant and most genetically diverse type, 
representing 33 sequences and clustering into 23 phylo-
genetically distinct lineages. Most of the isolates belonged 
to genotypes I and II, which are circulating in Southeast 
Asia (12). These genotypes represent dominant regional 
variants; only a few strains are closely related to viruses 
circulating in the Americas (genotype V, lineages 3–6) or 
to a genotype III virus in India. All but 3 DENV-2 isolates 
were the Cosmopolitan genotype, and the source popula-
tion was limited mostly to countries in Southeast Asia (on-
line Technical Appendix). 
DENV-2 phylogeny provides evidence for 7 phylo-
genetically distinct introductions of the virus into travel-
ers from Germany; the origins of these isolates were pre-
dominantly in Bali and the Philippines. DENV-3 sequences 
belonged to genotypes I–III; these isolates were closely 
related to lineages representing regional or local variants, 
except lineages 8 and 9 (online Technical Appendix).
A key phylogenetic pattern was the presence of a new 
lineage, L6 (online Technical Appendix), within DENV-
3 phylogeny comprising closely related isolates sampled 
from German, Taiwanese, and Chinese travelers return-
ing from Thailand and Laos during 2012–2014. A similar 
pattern of clustering to that for DENV-3 was observed for 
DENV-4 isolates. Thus, most DENV-4 from travelers were 
infected with genotype I and III strains closely related to 
lineages commonly sampled within Southeast Asia and to 
a genotype II isolate from Bolivia. A key phylogenetic pat-
tern was the presence of a new lineage, L3, within DENV-4 
phylogeny (online Technical Appendix) with sequences 
found in samples from patients tested during 2013–2015 
with travel histories to Thailand, China, and the Philippines 
(lineage 3). Lineage 3 was the most recently circulating lin-
eage detected in this study. This clustering is compatible 
with extensive viral traffic between Thailand, China, and 
the Philippines; Thailand, where most of the DENV infec-
tions were acquired, is thus a possible source of a virus 
population responsible for local or regional outbreaks.
Conclusions
Countries in Southeast Asia that are considered DENV 
hyperendemic are increasingly popular tourist destina-
tions for residents of Germany; thus, German travelers to 
these countries are potentially exposed to multiple types 
and genotypes of DENV. A high prevalence of DENV 
infection has been reported in travelers returning from 
DENV-endemic areas, emphasizing the importance of 
international travelers as potential sources of imported 
disease or sentinels for local outbreaks in DENV-free or 
non–DENV-endemic areas (2,3). The relative risk of in-
fection by country is difficult to calculate without atten-
tion to seasonal fluctuations in dengue fever incidence and 
travel patterns. Broadly speaking, though, among the top 
contributing countries mentioned, the comparative risk 
of infection with travel-associated DENV appears much 
higher in the Philippines and Indonesia (10% and 12.8% 
of the cases, compared with 1.7% and 2.8%, respectively, 
of travelers from Germany to DENV-endemic countries) 
than in Thailand (35.7% of the cases versus 15.0% of the 
Figure 1. Geographic origin of dengue viruses isolated from travelers returning to Germany, 2006–2015. 
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travelers) and the lowest in India (7.1% of the cases ver-
sus 18.5% of the travelers). 
We investigated DENV diversity and origin of in-
fection in travelers returning to Germany from DENV-
endemic areas and identified a high genetic diversity of 
DENV genotypes and lineages. Notably, 2 of these lin-
eages (DENV-3, genotype III, lineage 6 and DENV-4, 
genotype III, lineage 6) appear to have emerged very 
recently and are still responsible for local outbreaks in 
countries in Southeast Asia, thus reiterating the need to 
monitor the appearance and spread of novel lineages. 
Most investigated isolates were closely related to lin-
eages known to have circulated in Thailand, the Philip-
pines, and Indonesia, indicating that these countries serve 
as a major source of multiple DENV lineages (12). The 
observed high numbers of co-circulating lineages in the 
Thai, Indonesian, and Philippines source populations sup-
port the hypothesis of multiple geographic origins or ex-
tensive virus interchange among these countries (online 
Technical Appendix). 
Surveillance of symptomatic returned travelers can 
provide information on circulating DENV genotypes and 
lineages in heavily visited tourist areas and DENV-en-
demic regions. In Europe, the emergence of arboviruses 
should be particularly monitored because of the introduc-
tion and expansion of the DENV vector Aedes albopictus 
mosquito. In Germany, where recently introduced Ae. al-
bopictus mosquitos have spread in the southwestern part 
of the country, international travelers and the presence of 
competent vectors could potentially facilitate seasonal lo-
cal transmission of DENV (7,13,14). Our findings indicate 
a diverse array of imported DENV infections in travelers 
from Germany and emphasize the need for a continued 
surveillance of DENV infections in non–DENV-endemic 
regions as well as prompt and rapid serologic and molecu-
lar testing for DENV infection in febrile patients returning 
from DENV-endemic countries.
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